Showing results (1031-1040 of 1,523) with videos related to
Sort By:
Pageof 153
Current Cancer Drug Targets|April 1, 2017
Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic SignificanceLin-Jie Li, Yi-Long Wang, Lin-Qing Yuan, et al.Journal of Assisted Reproduction and Genetics|January 23, 2023
Decreased GDF9 and BMP15 in follicle fluid and granulosa cells and outcomes of IVF-ET among young patients with low prognosisTian-Hong Huang, Fu-Rui Chen, Ya-Nan Zhang, et al.Journal for Immunotherapy of Cancer|January 22, 2020
Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in <i>EGFR</i><i>/</i><i>ALK</i> wild-type advanced non-small cell lung cancerXiao-Xiao Peng, Ruoying Yu, Xue Wu, et al.Food Chemistry|May 18, 2022
Evaluation of digestibility differences for apple polyphenolics using in vitro elderly and adult digestion modelsYa-Fang Shang, Jun-Hao Miao, Jia Zeng, et al.JTO Clinical and Research Reports|August 11, 2025
Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed AnalysisJay M Lee, Alessandro Brunelli, Amy L Cummings, et al.Inorganic Chemistry|April 1, 2024
Hierarchical Hollow TiO<sub>2</sub>@Bi<sub>2</sub>WO<sub>6</sub> with Light-Driven Excited Bi<sup>(3-</sup> Sites for Efficient Photothermal Catalytic CO<sub>2</sub> ReductionWen-Rui Liu, Shen Yu, Zhan Liu, et al.Acta Biomaterialia|January 23, 2017
Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitroKai Hsia, Ming-Jie Yang, Wei-Min Chen, et al.Cancer Letters|June 24, 2017
EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIsZhiyong Liang, Ying Cheng, Yuan Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2018
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung CancerBenjamin J Solomon, Dong-Wan Kim, Yi-Long Wu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b TrialWanpu Yan, Wen-Zhao Zhong, Yan-Hui Liu, et al.Pageof 153